ArTS Archivio della ricerca di Trieste

POZZATO, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.149
EU - Europa 10.050
AS - Asia 8.960
SA - Sud America 1.324
AF - Africa 214
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 20
Totale 39.759
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.881
SG - Singapore 3.338
PL - Polonia 2.100
CN - Cina 2.044
UA - Ucraina 1.585
SE - Svezia 1.212
IT - Italia 1.190
HK - Hong Kong 1.122
BR - Brasile 1.039
VN - Vietnam 888
DE - Germania 781
FI - Finlandia 723
FR - Francia 591
KR - Corea 591
RU - Federazione Russa 419
GB - Regno Unito 383
IE - Irlanda 293
TR - Turchia 285
BG - Bulgaria 281
IN - India 158
CA - Canada 139
NL - Olanda 132
AR - Argentina 98
MX - Messico 87
JP - Giappone 83
BD - Bangladesh 70
CH - Svizzera 66
PK - Pakistan 59
BE - Belgio 58
MA - Marocco 54
IQ - Iraq 50
ES - Italia 47
EC - Ecuador 46
ZA - Sudafrica 41
AU - Australia 34
CO - Colombia 33
ID - Indonesia 32
PH - Filippine 32
SA - Arabia Saudita 32
AT - Austria 31
EG - Egitto 29
VE - Venezuela 29
CL - Cile 28
CZ - Repubblica Ceca 27
RO - Romania 25
IR - Iran 21
PY - Paraguay 19
UZ - Uzbekistan 18
JO - Giordania 17
SN - Senegal 17
KE - Kenya 16
TN - Tunisia 16
EU - Europa 14
TW - Taiwan 14
GR - Grecia 12
IL - Israele 12
PT - Portogallo 12
DZ - Algeria 10
KZ - Kazakistan 10
PE - Perù 10
UY - Uruguay 10
BO - Bolivia 9
LU - Lussemburgo 9
NO - Norvegia 9
TH - Thailandia 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
DK - Danimarca 8
HR - Croazia 8
LT - Lituania 8
MY - Malesia 8
PA - Panama 8
NP - Nepal 7
TT - Trinidad e Tobago 7
BY - Bielorussia 6
HU - Ungheria 6
KG - Kirghizistan 6
OM - Oman 6
RS - Serbia 6
AO - Angola 5
SY - Repubblica araba siriana 5
DO - Repubblica Dominicana 4
GD - Grenada 4
HN - Honduras 4
JM - Giamaica 4
LB - Libano 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
SI - Slovenia 4
AL - Albania 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
EE - Estonia 3
GE - Georgia 3
GY - Guiana 3
LK - Sri Lanka 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
A1 - Anonimo 2
BA - Bosnia-Erzegovina 2
Totale 39.703
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.961
Singapore 1.873
Ann Arbor 1.823
Warsaw 1.816
Fairfield 1.530
Ashburn 1.481
Jacksonville 1.392
Houston 1.382
Chandler 1.253
Hong Kong 1.105
San Jose 890
Wilmington 876
Hefei 636
Seoul 579
Seattle 573
Princeton 536
Cambridge 506
Boardman 433
Beijing 374
Chicago 339
Trieste 336
Dublin 288
Sofia 277
Columbus 264
Munich 257
Zgierz 257
Ho Chi Minh City 246
Lauterbourg 243
Izmir 242
Helsinki 224
Dallas 216
Hanoi 210
Moscow 187
Los Angeles 178
The Dalles 168
Santa Clara 134
Buffalo 133
Düsseldorf 103
San Diego 102
Dearborn 101
São Paulo 95
Frankfurt am Main 81
Milan 70
London 68
Council Bluffs 66
New York 66
Redwood City 59
Bern 56
Orem 51
Brussels 50
Toronto 50
Guangzhou 47
Porto Alegre 45
Shanghai 45
Phoenix 43
Haiphong 42
Norwalk 41
Verona 40
Tianjin 39
Da Nang 38
Tokyo 38
Turku 35
Rio de Janeiro 34
Casablanca 32
Redondo Beach 31
Dong Ket 30
Des Moines 29
Kunming 28
Montreal 28
Chennai 27
Jinan 27
Sacile 27
Denver 26
Mestre 26
Brooklyn 25
Ottawa 25
Falls Church 24
Nanjing 24
Belo Horizonte 23
Hangzhou 23
Nuremberg 23
Padova 23
Mumbai 22
Stockholm 22
Washington 22
Baghdad 21
Duino-Aurisina 21
Grafing 21
Lahore 21
Quito 21
Boston 20
Johannesburg 20
Amsterdam 19
Atlanta 18
Brasília 18
Brno 18
Manchester 18
Venezia 18
Dakar 17
Mexico City 17
Totale 27.578
Salva come PNG Salva come JPEG
Nome #
MBL2 Genetic Variants in HCV Infection Susceptibility, Spontaneous Viral Clearance and Pegylated Interferon Plus Ribavirin Treatment Response 479
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 471
KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival 470
Potential applications of nanocellulose-containing materials in the biomedical field 455
Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies 441
Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options. 402
Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines 398
NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: Evidence for a NOTCH1 mutation-driven epigenetic dysregulation 394
Usefulness of core needle biopsy for the diagnosis of thyroid Burkitt's lymphoma: a case report and review of the literature 356
Mutations in the 3' untranslated region (3' UTR) of NOTCH1 are associated with low CD20 expression levels in chronic lymphocytic leukemia 341
Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis 337
Survival and Prognostic Factors in Mixed Cryoglobulinemia: Data from 246 Cases 321
New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles. 300
The role of the transcription factor E2F1 in hepatocellular carcinoma 292
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells 282
Serum Response Factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6 279
Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs 278
A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles 270
CD209 promoter polymorphisms associate with HCV infection and pegylated-interferon plus ribavirin treatment response 261
Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs 255
Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels. 250
Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects 248
Diagnostic and prognostic role of eEF1A in chronic lymphocytic leukaemia 244
Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application. 239
NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components 239
Metastatic angioimmunoblastic T-cell lymphoma started from thoracic paravertebral region: a Case report 236
A case of burkitt-like B lymphoblastic lymphoma 235
Impact of DEFB1 gene regulatory polymorphisms on hBD-1 salivary concentration 235
DEFB1 polymorphisms and salivary hBD-1 concentration in Oral Lichen Planus patients and healthy subjects 235
Translation Elongation 233
Impairment of the Pin1/E2F1 axis in the anti-proliferative effect of bortezomib in hepatocellular carcinoma cells 233
Effects of E2F1-cyclinE1-E2 circuit down-regulation in hepatocellular carcinoma cells 232
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia. 232
Blood flow changes in hepatocellular carcinomas after the administration of Thaliodomide by reperfusion kinetics during microbubble infusion: Preliminary results. 229
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia. 225
Aptamers as nano-targeting delivery devices or anti-cancer drugs for fighting tumours 224
CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism. 220
A transient cutaneous relapse of AML M1 in hematological remission: A case report 219
Haemochromatosis gene mutations in a clustered Italian population: evidence of high prevalence in people of Celtic ancestry. 214
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 210
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 203
S-adenosylmethionine counteracts oral contraceptive hepatotoxicity in women 201
Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells 201
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia 200
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials 198
Galactosylated polyaspartamide copolymers for siRNA targeted delivery to hepatocellular carcinoma cells 193
Evaluation of the contribution of the elongational factor 1 A isoforms in hepatocellular carcinoma celss growth 193
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage. 191
A new genotype: typical of Italy? 190
5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway 190
ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles ofTP53disrupted chronic lymphocytic leukaemia cells 189
Introduction 188
Bortezomib effect of E2F and cyclin family members in human hepatocellular carcinoma cell lines 185
HLA-G regulatory polymorphisms are associated with susceptibility to HCV infection 184
Abnormality in the hepatic transport of Rifamycin-SV in Gilbert's syndrome 183
A randomized trial comparing different alfa-interferon at different dose and duration as therapy for chronic hepatitis C. 178
Improving siRNA Bio-Distribution and Minimizing Side Effects 177
Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. 174
DEVELOPMENT OF CHLORAMBUCIL/HYDROXYCHLOROQUINE-LOADED ANTI-CD20 NANOPARTICLES FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA : IN VITRO MODEL 174
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. 173
Acute high-dose ethanol modulates glutathione levels to different degrees in various organs of the rat. 173
Randomized trial of combination therapy in relapser or non-responder HCV patients 173
ALCOHOL HEPATIC TOXICITY IN RAT: EVIDENCE OF THE UTILITY OF THE GASTRIC ETHANOL METABOLISM 172
No evidence of Polyomavirus and EBV infections in Italian patients with mixed cryoglobulinemia infected chronically with HCV 172
Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands? 172
The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells 172
Effects of chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles on a human/mouse model of Burkitt lymphoma 170
Aptamers as targeting delivery devices or anti-cancer drugs for fighting tumors 170
Merkel-cell polyomavirus and B-cell chronic lymphocytic leukemia 169
A multicentre randomized clinical trial of recombinant alpha-2a interferon therapy in patients with chronic hepatitis B 169
Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease 168
Long-term effects of the new direct antiviral agents (DAAs) therapy for HCV-related mixed cryoglobulinaemia without renal involvement: a multicentre open-label study 168
The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells 168
Hematologic problems in the Critically III 167
Abnormal serum gamma-glutamyltranspeptidase in alcoholics: clues to its explanation 167
A novel animal model to study non-spontaneous bisphosphonates osteonecrosis of jaw. 167
BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199 164
Influence of acid-secretion blockers on gastric and hepatic alcohol dehydrogenase in rat 164
CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia. 163
Typing hepatitis C virus by polymerase chain reaction with type-specific primers: relationship to the severity of liver disease and response to the alpha-interferon therapy. 162
TP53 mutations with low variant allele frequency predict short survival in Chronic Lymphocytic Leukemia 160
Targeted delivery of siRNAs against hepatocellular carcinoma-related genes by a galactosylated polyaspartamide copolymer 159
Xenograft zebrafish models for the development of novel anti-hepatocellular carcinoma molecules 159
Human leucocyte interferon-alpha in the treatment of chronic hepatitis C 158
Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C. 155
Systematic review of purine analog treatment for chronic lymphocytic leukemia: lessons for future trials 155
The targeting of the elongation factor 1A by a DNA aptamer impairs the viability of hepatocarcinoma cells 155
Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration. 154
Gastric and hepatic glutathione after ethanol load: the role of first-pass metabolism and effects of antisecretive drugs. 154
Hepatitis C virus- related cryoglobulinemic vasculitis: A review of the role of the new direct antiviral agents (DAAs) therapy 154
Low-grade malignant lymphoma, hepatitis C virus infection and mixed cryoglobulinemia. 153
Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas 152
Influence of ascitic fluid characteristics on coagulation disorders after implantation of Le Veen peritoneo-jugular shunt. 152
B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinemia syndrome and hepatitis-C virus infection 151
null 150
Quantitative analysis of hepatitis C virus RNA in liver biopsies by competitive reverse transcription and polymerase chain reaction. 149
SiRNAs targeted against cyclin E1, cyclin E2 and E2F1 down regulate the growth of Hepatocellular Carcinoma showing their potential use in the prevention of this type of tumor 149
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C. 149
Alcool: effetto di primo passaggio e sistemi redox 148
Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors. 147
Totale 21.912
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.761
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021947 0 0 0 0 0 0 0 0 0 437 119 391
2021/20222.722 71 235 151 344 42 156 100 139 367 304 166 647
2022/20233.443 376 378 295 454 374 646 29 263 406 36 125 61
2023/20242.013 165 132 84 98 159 154 296 503 21 63 162 176
2024/20254.890 117 144 308 392 412 464 353 373 824 618 398 487
2025/202610.382 858 691 915 995 1.004 1.208 1.797 401 1.329 1.184 0 0
Totale 40.348